PE20091224A1 - Composicion farmaceutica en la forma de polvos encapsulados que comprende orlistat y su procedimiento de preparacion - Google Patents
Composicion farmaceutica en la forma de polvos encapsulados que comprende orlistat y su procedimiento de preparacionInfo
- Publication number
- PE20091224A1 PE20091224A1 PE2007001452A PE2007001452A PE20091224A1 PE 20091224 A1 PE20091224 A1 PE 20091224A1 PE 2007001452 A PE2007001452 A PE 2007001452A PE 2007001452 A PE2007001452 A PE 2007001452A PE 20091224 A1 PE20091224 A1 PE 20091224A1
- Authority
- PE
- Peru
- Prior art keywords
- mixtures
- weight
- pharmaceutical composition
- sodium
- talc
- Prior art date
Links
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 title abstract 2
- 229960001243 orlistat Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000000843 powder Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 2
- 229940075614 colloidal silicon dioxide Drugs 0.000 abstract 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- 239000004094 surface-active agent Substances 0.000 abstract 2
- 239000000454 talc Substances 0.000 abstract 2
- 229910052623 talc Inorganic materials 0.000 abstract 2
- 235000012222 talc Nutrition 0.000 abstract 2
- 229920002261 Corn starch Polymers 0.000 abstract 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 229930195725 Mannitol Natural products 0.000 abstract 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 102000019280 Pancreatic lipases Human genes 0.000 abstract 1
- 108050006759 Pancreatic lipases Proteins 0.000 abstract 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- 235000021355 Stearic acid Nutrition 0.000 abstract 1
- 239000006096 absorbing agent Substances 0.000 abstract 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 abstract 1
- 239000008116 calcium stearate Substances 0.000 abstract 1
- 235000013539 calcium stearate Nutrition 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000008120 corn starch Substances 0.000 abstract 1
- 238000010790 dilution Methods 0.000 abstract 1
- 239000012895 dilution Substances 0.000 abstract 1
- 239000007884 disintegrant Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 239000000314 lubricant Substances 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 239000000594 mannitol Substances 0.000 abstract 1
- 235000010355 mannitol Nutrition 0.000 abstract 1
- 229940016286 microcrystalline cellulose Drugs 0.000 abstract 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 abstract 1
- 239000008108 microcrystalline cellulose Substances 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 abstract 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 abstract 1
- 229940116369 pancreatic lipase Drugs 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 abstract 1
- 229940079832 sodium starch glycolate Drugs 0.000 abstract 1
- 239000008109 sodium starch glycolate Substances 0.000 abstract 1
- 229920003109 sodium starch glycolate Polymers 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
- 239000008117 stearic acid Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CL2007002287A CL53426B (enrdf_load_stackoverflow) | 2007-08-06 | 2007-08-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20091224A1 true PE20091224A1 (es) | 2009-08-26 |
Family
ID=51359501
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2007001452A PE20091224A1 (es) | 2007-08-06 | 2007-10-25 | Composicion farmaceutica en la forma de polvos encapsulados que comprende orlistat y su procedimiento de preparacion |
Country Status (7)
| Country | Link |
|---|---|
| CL (1) | CL53426B (enrdf_load_stackoverflow) |
| CR (1) | CR10132A (enrdf_load_stackoverflow) |
| DO (1) | DOP2008000021A (enrdf_load_stackoverflow) |
| MX (1) | MX2008010082A (enrdf_load_stackoverflow) |
| PA (1) | PA8786701A1 (enrdf_load_stackoverflow) |
| PE (1) | PE20091224A1 (enrdf_load_stackoverflow) |
| SV (1) | SV2009002991A (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL216542B1 (pl) * | 2008-03-20 | 2014-04-30 | Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna | Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku |
-
2007
- 2007-08-06 CL CL2007002287A patent/CL53426B/es active
- 2007-10-25 PE PE2007001452A patent/PE20091224A1/es active IP Right Grant
-
2008
- 2008-04-10 DO DO2008000021A patent/DOP2008000021A/es unknown
- 2008-07-01 PA PA20088786701A patent/PA8786701A1/es unknown
- 2008-07-07 CR CR10132A patent/CR10132A/es not_active Application Discontinuation
- 2008-07-31 SV SV2008002991A patent/SV2009002991A/es unknown
- 2008-08-06 MX MX2008010082A patent/MX2008010082A/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| CR10132A (es) | 2008-10-28 |
| DOP2008000021A (es) | 2009-11-30 |
| PA8786701A1 (es) | 2009-04-23 |
| CL53426B (enrdf_load_stackoverflow) | 2016-11-28 |
| SV2009002991A (es) | 2009-04-16 |
| CL2007002287A1 (enrdf_load_stackoverflow) | 2007-12-14 |
| MX2008010082A (es) | 2009-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA97489C2 (ru) | Фармацевтическая композиция, которая содержит аморфный розувастатин кальция | |
| PE20070165A1 (es) | Formulacion de comprension directa que comprende un inhibidor de dipeptidil-peptidasa iv y una glitazona | |
| GT200600194A (es) | Composiciones farmaceuticas conteniendo imatinib y un componente de liberacion prolongada | |
| MX2010004897A (es) | Forma de dosificacion oralmente desintegrada. | |
| NO20084612L (no) | Oralt opploselige tabletter | |
| ES2812198T1 (es) | Formulación de disolución rápida de un compuesto activo-receptor de calcio | |
| RS51330B (en) | STABLE PHARMACEUTICAL FORMULATIONS OF MONTELUKAST SODIUM | |
| EA029081B9 (ru) | Комбинированный состав двух противовирусных соединений | |
| HRP20211752T1 (hr) | Farmaceutski pripravci 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioksol-5-il)ciklopropankarboksamido)-3-metilpiridin-2-il)benzojeve kiseline i njihova primjena | |
| DE602005020655D1 (de) | Carboxamid-spirolactam-cgrp-rezeptor-antagonisten | |
| NO20085110L (no) | Substituerte spirosykliske CGRP-reseptorantagonister | |
| MX2008012731A (es) | Tabletas de paracetamol de liberacion rapida. | |
| RS54329B1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING RIFAXIMINE, PROCEDURES FOR THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF VAGINAL INFECTIONS | |
| RU2008135718A (ru) | Композиции клопидогреля бисульфата | |
| ATE493412T1 (de) | Spirohydantoin-aryl-cgrp-rezeptorantagonisten | |
| CR9953A (es) | Diarilurea para el tratamiento de hipertension pulmonar | |
| MX2011011928A (es) | Procedimiento y composicion para mejorar la absorcion de agentes terapeuticos. | |
| DK1996160T3 (da) | Bioresorberbar sammensætning med kontrolleret frigivelse | |
| AR077546A1 (es) | Formulaciones de comprimidos de 3-cianoquinolina y usos de los mismos | |
| SG178975A1 (en) | Indenone derivative and pharmaceutical composition comprising same | |
| CR20110209A (es) | Composición farmacéutica sólida | |
| AR061093A1 (es) | Composiciones de calcio | |
| TR201101807T2 (tr) | Rosuvastatin kalsiyumun farmasotik bileşimleri | |
| RU2008139625A (ru) | Композиции и способы лечения ревматоидного артрита | |
| PE20091224A1 (es) | Composicion farmaceutica en la forma de polvos encapsulados que comprende orlistat y su procedimiento de preparacion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |